As of 2024-12-13, the EV/EBITDA ratio of BioLife Solutions Inc (BLFS) is -392.01. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLFS's latest enterprise value is 1,211.72 mil USD. BLFS's TTM EBITDA according to its financial statements is -3.09 mil USD. Dividing these 2 quantities gives us the above BLFS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.7x - 12.2x | 9.9x |
| Forward P/E multiples | 9.0x - 11.1x | 10.3x |
| Fair Price | (0.55) - (0.69) | (0.62) |
| Upside | -102.1% - -102.6% | -102.3% |
| Date | EV/EBITDA |
| 2024-12-11 | -392.01 |
| 2024-12-10 | -390.22 |
| 2024-12-09 | -391.27 |
| 2024-12-06 | -390.82 |
| 2024-12-05 | -375.00 |
| 2024-12-04 | -392.91 |
| 2024-12-03 | -399.33 |
| 2024-12-02 | -406.20 |
| 2024-11-29 | -409.18 |
| 2024-11-27 | -404.55 |
| 2024-11-26 | -403.06 |
| 2024-11-25 | -398.73 |
| 2024-11-22 | -387.39 |
| 2024-11-21 | -378.13 |
| 2024-11-20 | -372.46 |
| 2024-11-19 | -334.10 |
| 2024-11-18 | -304.69 |
| 2024-11-15 | -312.90 |
| 2024-11-14 | -322.30 |
| 2024-11-13 | -359.03 |
| 2024-11-12 | -394.70 |
| 2024-11-11 | -396.19 |
| 2024-11-08 | -389.18 |
| 2024-11-07 | -389.33 |
| 2024-11-06 | -396.19 |
| 2024-11-05 | -386.04 |
| 2024-11-04 | -380.67 |
| 2024-11-01 | -358.43 |
| 2024-10-31 | -348.43 |
| 2024-10-30 | -358.28 |
| 2024-10-29 | -351.26 |
| 2024-10-28 | -340.37 |
| 2024-10-25 | -327.98 |
| 2024-10-24 | -321.71 |
| 2024-10-23 | -326.63 |
| 2024-10-22 | -336.63 |
| 2024-10-21 | -342.61 |
| 2024-10-18 | -351.86 |
| 2024-10-17 | -344.55 |
| 2024-10-16 | -341.71 |
| 2024-10-15 | -349.02 |
| 2024-10-14 | -349.02 |
| 2024-10-11 | -336.49 |
| 2024-10-10 | -330.51 |
| 2024-10-09 | -348.43 |
| 2024-10-08 | -353.50 |
| 2024-10-07 | -356.64 |
| 2024-10-04 | -365.44 |
| 2024-10-03 | -362.31 |
| 2024-10-02 | -361.71 |